Annual Cash & Cash Equivalents
$3.03 M
-$4.51 M-59.85%
December 31, 2023
Summary
- As of February 7, 2025, BBLG annual cash & cash equivalents is $3.03 million, with the most recent change of -$4.51 million (-59.85%) on December 31, 2023.
- During the last 3 years, BBLG annual cash & cash equivalents has risen by +$3.03 million (+100.00%).
- BBLG annual cash & cash equivalents is now -59.85% below its all-time high of $7.54 million, reached on December 31, 2022.
Performance
BBLG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.57 M
+$1.23 M+52.93%
September 30, 2024
Summary
- As of February 7, 2025, BBLG quarterly cash and cash equivalents is $3.57 million, with the most recent change of +$1.23 million (+52.93%) on September 30, 2024.
- Over the past year, BBLG quarterly cash and cash equivalents has increased by +$1.23 million (+52.93%).
- BBLG quarterly cash and cash equivalents is now -52.69% below its all-time high of $7.54 million, reached on December 31, 2022.
Performance
BBLG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BBLG Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.9% | +52.9% |
| 3 y3 years | +100.0% | -49.1% |
| 5 y5 years | +216.8% | -49.1% |
BBLG Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.9% | at low | -52.7% | +52.9% |
| 5 y | 5-year | -59.9% | -100.0% | -52.7% | -100.0% |
| alltime | all time | -59.9% | -100.0% | -52.7% | -100.0% |
Bone Biologics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.57 M(+52.9%) |
| Jun 2024 | - | $2.33 M(-27.7%) |
| Mar 2024 | - | $3.23 M(+6.6%) |
| Dec 2023 | $3.03 M(-59.9%) | $3.03 M(-32.0%) |
| Sep 2023 | - | $4.45 M(-36.5%) |
| Jun 2023 | - | $7.01 M(+13.2%) |
| Mar 2023 | - | $6.19 M(-17.9%) |
| Dec 2022 | $7.54 M(+12.9%) | $7.54 M(+49.0%) |
| Sep 2022 | - | $5.06 M(-7.2%) |
| Jun 2022 | - | $5.45 M(-6.2%) |
| Mar 2022 | - | $5.81 M(-12.9%) |
| Dec 2021 | $6.68 M(>+9900.0%) | $6.68 M(>+9900.0%) |
| Sep 2021 | - | $3400.00(-22.7%) |
| Jun 2021 | - | $4400.00(-93.8%) |
| Mar 2021 | - | $71.20 K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00(-100.0%) |
| Sep 2020 | - | $2500.00(>+9900.0%) |
| Jun 2020 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $2400.00(-90.0%) |
| Dec 2019 | $24.10 K(-97.5%) | $24.10 K(-88.1%) |
| Sep 2019 | - | $201.80 K(+14.4%) |
| Jun 2019 | - | $176.40 K(-75.7%) |
| Mar 2019 | - | $726.40 K(-24.0%) |
| Dec 2018 | $955.40 K(+38.4%) | $955.40 K(-58.4%) |
| Sep 2018 | - | $2.29 M(+653.2%) |
| Jun 2018 | - | $304.60 K(-18.0%) |
| Mar 2018 | - | $371.40 K(-46.2%) |
| Dec 2017 | $690.30 K(+11.3%) | $690.30 K(-57.4%) |
| Sep 2017 | - | $1.62 M(+107.2%) |
| Jun 2017 | - | $783.00 K(-51.4%) |
| Mar 2017 | - | $1.61 M(+159.9%) |
| Dec 2016 | $620.40 K(-44.4%) | $620.40 K(-9.9%) |
| Sep 2016 | - | $688.20 K(-68.6%) |
| Jun 2016 | - | $2.19 M(-48.0%) |
| Mar 2016 | - | $4.22 M(+278.5%) |
| Dec 2015 | $1.12 M(-58.1%) | $1.12 M |
| Dec 2014 | $2.66 M | - |
FAQ
- What is Bone Biologics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bone Biologics?
- What is Bone Biologics annual cash & cash equivalents year-on-year change?
- What is Bone Biologics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bone Biologics?
- What is Bone Biologics quarterly cash and cash equivalents year-on-year change?
What is Bone Biologics annual cash & cash equivalents?
The current annual cash & cash equivalents of BBLG is $3.03 M
What is the all time high annual cash & cash equivalents for Bone Biologics?
Bone Biologics all-time high annual cash & cash equivalents is $7.54 M
What is Bone Biologics annual cash & cash equivalents year-on-year change?
Over the past year, BBLG annual cash & cash equivalents has changed by -$4.51 M (-59.85%)
What is Bone Biologics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BBLG is $3.57 M
What is the all time high quarterly cash and cash equivalents for Bone Biologics?
Bone Biologics all-time high quarterly cash and cash equivalents is $7.54 M
What is Bone Biologics quarterly cash and cash equivalents year-on-year change?
Over the past year, BBLG quarterly cash and cash equivalents has changed by +$1.23 M (+52.93%)